Dr. Maen Abdelrahim, MD
Claim this profileHouston Methodist
Studies Liver Cancer
Studies Pancreatic Adenocarcinoma
10 reported clinical trials
22 drugs studied
Area of expertise
1Liver Cancer
Stage I
Stage II
2Pancreatic Adenocarcinoma
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Maen Abdelrahim, MD is currently running
Atezolizumab + Bevacizumab
for Liver Cancer
Patients with hepatocellular carcinoma (HCC) beyond Milan Criteria (MC) who are transplant-eligible will be treated with 6 months of neoadjuvant/downstaging atezolizumab plus bevacizumab while receiving standard of care transarterial chemoembolization (TACE). We hypothesize that atezolizumab and bevacizumab can appropriately bridge patients with HCC beyond MC to transplantation and not increase the risk of 1-year post-transplant rejection.
Recruiting3 awards Phase 410 criteria
BMS-986340 + Nivolumab/Docetaxel
for Cancer
This trial tests a new drug, BMS-986340, alone and with other cancer treatments (nivolumab and docetaxel) in patients with advanced solid tumors. The goal is to find out if it is safe and effective in treating these cancers.
Recruiting1 award Phase 1 & 26 criteria
More about Maen Abdelrahim, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Maen Abdelrahim, MD has experience with
- Gemcitabine
- Bevacizumab
- Atezolizumab
- Lenvatinib
- Transcatheter Arterial Chemoembolization
- NovoTTF-200T
Breakdown of trials Maen Abdelrahim, MD has run
Liver Cancer
Pancreatic Adenocarcinoma
Stomach Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Maen Abdelrahim, MD specialize in?
Maen Abdelrahim, MD focuses on Liver Cancer and Pancreatic Adenocarcinoma. In particular, much of their work with Liver Cancer has involved Stage I patients, or patients who are Stage II.
Is Maen Abdelrahim, MD currently recruiting for clinical trials?
Yes, Maen Abdelrahim, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Maen Abdelrahim, MD has studied deeply?
Yes, Maen Abdelrahim, MD has studied treatments such as Gemcitabine, Bevacizumab, Atezolizumab.
What is the best way to schedule an appointment with Maen Abdelrahim, MD?
Apply for one of the trials that Maen Abdelrahim, MD is conducting.
What is the office address of Maen Abdelrahim, MD?
The office of Maen Abdelrahim, MD is located at: Houston Methodist, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.